"ctsr-enhanced car T cells to overcome the tumor microenvironment and improve immunotherapy for pediatric brain tumors
Active Project Grant Awarded Last action
- Award ID
- HT9425261E379
- Recipient
-
Children's Hospital LOS Angeles UEI DVL1CMRMWRN9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,400,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 7% complete
- Place of performance
- Los Angeles, CA 90027, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded Children's Hospital Los Angeles $1.4 million on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to develop CTSR-enhanced CAR T cells to overcome the tumor microenvironment and improve immunotherapy for pediatric brain tumors. Performance runs through August 31, 2029, at the hospital's Los Angeles, California facility. The award supports advanced biomedical research intended to transform health care for Service Members and the American public through innovative and impactful research solutions.
Quick answers
Who received award HT9425261E379?
HT9425261E379 was awarded to Children's Hospital LOS Angeles by Defense Health Agency (Department of Defense) on September 1, 2026.
How much is award HT9425261E379 worth?
$1,400,000 has been obligated on HT9425261E379.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award